The Ugly Story Behind the Laetrile Cover-Up

The Most Revolutionary Act

Second Opinion: Laetrile at Sloan Kettering

Eric Merola (2014)

Film Review

Second Opinion is a documentary about the deliberate cover-up of an alternative cancer treatment by Sloan Kettering Cancer Center, America’s foremost cancer research institution, and Dr Robert Moss, the Sloan Kettering science writer who exposed the cover-up.

As strange as it may seem Sloan Kettering themselves did the definitive research showing that Laetrile (aka Amygdalin and B17) is effective in small tumors in early stage cancer. Sloan Kettering even went so far as to apply to the FDA (in 1974 and 1975) for permission to conduct human Laetrile trials.

A year later, under massive pressure from the National Cancer Institute and American Cancer Society (both receive major funding from Big Pharma), the top brass at Sloan Kettering reversed themselves and falsely claimed that twenty laetrile studies over four years showed no beneficial effect whatsoever. As one commentator observed, if…

View original post 444 more words

Advertisements

One thought on “The Ugly Story Behind the Laetrile Cover-Up

  1. stuartbramhall

    Thanks for reblogging. It’s really important to let people know about the alternatives to radiation therapy and chemotherapy – which often impair the ability to fight cancer because they damage the immune system.

    Liked by 1 person

    Reply

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s